Greenwich LifeSciences In... (GLSI)

AI Score

Unlock

8.95

0.11 (1.24%)

At close: Apr 17, 2025, 3:59 PM

8.75

-2.23%

After-hours: Apr 17, 2025, 07:41 PM EDT

Greenwich LifeSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net Income	-15.79M	-10.5M	-10.22M	-9.24M	-8.89M	-8.94M	-8.86M	-7.98M	-7.83M	-7.4M	-5.94M	-5.94M	-4.57M	-3.36M	-2.75M	-2.22M	-1.86M	-1.05M	-1.13M	-3.52M	-3.43M	-3.09M	-2.75M	-148.73K
Depreciation & Amortization	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	3.61K	2.71K	1.8K	902.00
Stock-Based Compensation	7.25M	2.38M	2.38M	2.38M	2.38M	2.38M	2.54M	2.17M	1.74M	1.31M	720.25K	660.8K	660.58K	660.2K	660.2K	669.1K	677.99K	707.88K	542.83K	368.89K	194.94K	n/a	n/a	n/a
Other Working Capital	-921.22K	1.24K	16.71K	107.92K	75.65K	128.97K	72.41K	-5.59K	-122.27K	-142.24K	-16.73K	-25.22K	141.57K	76.17K	17.83K	73.94K	120.95K	37.51K	97.41K	2.66M	2.54M	2.68M	2.55M	-47.46K
Other Non-Cash Items	1.77M	1.08M	1.67M	2.27M	2.36M	2.39M	2.55M	2.18M	1.75M	3.36M	3.1M	3.04M	3.16M	1.31M	830.96K	664.1K	377.25K	15K	200.2K	207.8K	323.09K	323.09K	122.89K	115.29K
Deferred Income Tax	n/a	-570.91K	-1.17M	-1.76M	-2.36M	-2.39M	-2.55M	-2.18M	-1.58M	-3.2M	-2.44M	-2.21M	-2.21M	-362.25K	-362.25K	-362.25K	-362.25K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	545.1K	1.05M	154.04K	31.5K	59.41K	72.41K	-5.59K	-122.27K	-217.24K	-423.46K	-431.95K	-385.17K	-483.11K	-194.72K	-138.61K	28.4K	122.82K	367.92K	2.93M	2.81M	2.88M	2.55M	-47.46K
Operating Cash Flow	-7.27M	-7.57M	-6.79M	-6.7M	-6.48M	-6.49M	-6.24M	-5.81M	-6.2M	-6.29M	-5.64M	-5.71M	-4.29M	-3.18M	-2.29M	-1.68M	-1.15M	-214.17K	-213.27K	-213.27K	-293.27K	-79.1K	-80K	-80K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-7.54M	-7.54M	-9.56M	-15.07M	-7.54M	-7.54M	-5.51M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.37M	1.18M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-275.15K	-635.15K	-635.15K	-635.15K	-360K	215K	215K	215K	215K	n/a	n/a	n/a
Financial Cash Flow	4.37M	4.25M	3.07M	299.12K	n/a	-7.54M	-7.54M	-9.56M	-15.07M	-6.97M	-6.97M	-4.95M	2.84M	25.87M	32.08M	32.08M	29.81M	6.42M	215K	215K	215K	n/a	n/a	n/a
Net Cash Flow	-2.9M	-3.32M	-3.72M	-6.41M	-6.48M	-6.49M	-6.24M	-7.83M	-13.74M	-13.27M	-12.61M	-10.66M	-1.46M	22.69M	29.79M	30.4M	28.65M	6.21M	1.73K	1.73K	-78.27K	-79.1K	-80K	-80K
Free Cash Flow	-7.27M	-7.57M	-6.79M	-6.7M	-6.48M	-6.49M	-6.24M	-5.81M	-6.2M	-6.29M	-5.64M	-5.71M	-4.29M	-3.18M	-2.29M	-1.68M	-1.15M	-214.17K	-213.27K	-213.27K	-293.27K	-79.1K	-80K	-80K